NCT00586378View on ClinicalTrials.gov

Ovatio DR and VR Implantable Cardioverter Defibrillators Post-approval Study

PHASE3CompletedINTERVENTIONAL

Enrollment

85

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Sudden Cardiac Death

Interventions

DEVICE

Ovatio DR and Ovatio VR

implantable cardioverter defibrillator

Trial Locations (1)

85206

Banner Baywood, Mesa

Sponsors

Lead Sponsor

ELA Medical, Inc.

All Listed Sponsors

lead

ELA Medical, Inc.

INDUSTRY

NCT00586378 - Ovatio DR and VR Implantable Cardioverter Defibrillators Post-approval Study | Biotech Hunter | Biotech Hunter